These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6143608)

  • 1. In vivo protection of penicillin-susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce beta-lactamase.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    Can J Microbiol; 1984 Jan; 30(1):98-104. PubMed ID: 6143608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism between penicillin, clindamycin, or metronidazole and gentamicin against species of the Bacteroides melaninogenicus and Bacteroides fragilis groups.
    Brook I; Coolbaugh JC; Walker RI; Weiss E
    Antimicrob Agents Chemother; 1984 Jan; 25(1):71-7. PubMed ID: 6142680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo protection of group A beta-haemolytic streptococci from penicillin by beta-lactamase-producing Bacteroides species.
    Brook I; Pazzaglia G; Coolbaugh JC; Walker RI
    J Antimicrob Chemother; 1983 Dec; 12(6):599-606. PubMed ID: 6363381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibiotic and clavulanic acid treatment of subcutaneous abscesses caused by Bacteroides fragilis alone or in combination with aerobic bacteria.
    Brook I; Coolbaugh JC; Walker RI
    J Infect Dis; 1983 Jul; 148(1):156-9. PubMed ID: 6350486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of encapsulated Bacteroides melaninogenicus and Bacteroides fragilis groups in mixed infections.
    Brook I; Walker RI
    Infect Immun; 1984 Apr; 44(1):12-5. PubMed ID: 6142862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus.
    Murray PR; Rosenblatt JE
    Antimicrob Agents Chemother; 1977 Apr; 11(4):605-8. PubMed ID: 16564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of antimicrobial therapy on mixed infections with Bacteroides species. Is eradication of the anaerobes important?
    Brook I
    J Infect; 1991 Jan; 22(1):27-35. PubMed ID: 2002230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Lactamase-producing bacteria recovered after clinical failures with various penicillin therapy.
    Brook I
    Arch Otolaryngol; 1984 Apr; 110(4):228-31. PubMed ID: 6608346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of beta-lactamase producing bacteria in subgingival plaque and their sensitivity to Augmentin.
    Legg JA; Wilson M
    Br J Oral Maxillofac Surg; 1990 Jun; 28(3):180-4. PubMed ID: 1983762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clindamycin, metronidazole, and penicillin for the treatment of experimental infections in mice caused by beta-lactamase-producing Bacteroides intermedius.
    Cockerill FR; Rosenblatt JE; Lee DT; Gay JD
    Diagn Microbiol Infect Dis; 1986 May; 5(1):25-30. PubMed ID: 3486740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenicity of encapsulated Bacteroides melaninogenicus group, B. oralis and B. ruminicola subsp. brevis in abscesses in mice.
    Brook I; Gillmore JD; Coolbaugh JC; Walker RI
    J Infect; 1983 Nov; 7(3):218-26. PubMed ID: 6141205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain abscess due to penicillin- and clindamycin-resistant Bacteroides melaninogenicus.
    Villar LA; Massanari RM; Koontz FP
    Surg Neurol; 1983 Dec; 20(6):453-5. PubMed ID: 6139884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta-lactamase-producing bacteria in respiratory tract infections.
    Brook I
    Scand J Infect Dis Suppl; 1988; 57():41-9. PubMed ID: 3074471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence and persistence of beta-lactamase-producing bacteria in the oropharynx following penicillin treatment.
    Brook I
    Arch Otolaryngol Head Neck Surg; 1988 Jun; 114(6):667-70. PubMed ID: 3130087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy between spiramycin and metronidazole in the treatment of polymicrobial infections.
    Brook I
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():77-85. PubMed ID: 3141350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of bacterial interference and beta-lactamase production in management of experimental infection with group A beta-hemolytic streptococci.
    Brook I; Gilmore JD
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1452-5. PubMed ID: 8363375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection.
    Brook I
    Rev Infect Dis; 1984; 6(5):601-7. PubMed ID: 6390637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct and indirect pathogenicity of beta-lactamase-producing bacteria in mixed infections in children.
    Brook I
    Crit Rev Microbiol; 1989; 16(3):161-80. PubMed ID: 2644068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of anaerobic beta-lactamase-producing bacteria in upper respiratory tract infections.
    Brook I
    Pediatr Infect Dis J; 1987 Mar; 6(3):310-6. PubMed ID: 3554127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.